Monday, December 14, 2015

FDA grants Roche's Alecensa (alectinib) accelerated approval for people with a specific type of lung cancer

… (ALK)-positive, metastatic non-small cell lung cancer (NSCLC) who have progressed on … Roche Group. About Roche in lung cancer Lung cancer is a major area of … for every person diagnosed with lung cancer. We currently have two approved … to treat certain kinds of lung cancer and more than ten medicines …

No comments:

Post a Comment